SWITCHING OUT OF CLASS OR TO ANOTHER ANTI-TNF AGENT IS THE BEST STRATEGY FOR CLINICAL EFFICACY AND TREATMENT PERSISTENCE IN IBD PATIENTS WITH ANTI-DRUG ANTIBODIES AGAINST ANTI-TNF

被引：0
|
作者：
Anjie, Suzanne I.
Hanzel, Jurij
Gecse, Krisztina B.
D'Haens, Geert
Brandse, Johannan F.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1774
引用
收藏
页码：S1120 / S1121
页数：2
相关论文
共 50 条
  • [31] Immunogenicity, the elephant in the room. Comment on "Drug levels, anti-drug antibodies and clinical efficacy of the anti-TNFα biologics in rheumatic diseases"
    Pixley, John
    CLINICAL RHEUMATOLOGY, 2013, 32 (10) : 1413 - 1413
  • [32] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Nicholas J. Costable
    Zachary A. Borman
    Jiayi Ji
    Marla C. Dubinsky
    Ryan C. Ungaro
    Digestive Diseases and Sciences, 2022, 67 : 2480 - 2484
  • [33] High level of anti-drug antibodies after intra-articular injection of anti-TNF
    Zufferey, Pascal
    Perreau, Mathieu
    So, Alexander
    RHEUMATOLOGY, 2015, 54 (12) : 2291 - 2292
  • [34] PRIOR IMMUNOGENICITY TO ANTI-TNF BIOLOGICS IS NOT ASSOCIATED WITH INCREASED ANTI-DRUG ANTIBODIES TO VEDOLIZUMAB OR USTEKINUMAB
    Costable, Nicholas J.
    Borman, Zachary A.
    Phan, Becky L.
    Ji, Jiayi
    Dubinsky, Marla
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2020, 158 (06) : S468 - S469
  • [35] Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
    Costable, Nicholas J.
    Borman, Zachary A.
    Ji, Jiayi
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2480 - 2484
  • [36] Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial
    Roblin, Xavier
    Williet, Nicolas
    Boschetti, Gilles
    Phelip, Jean-Marc
    Del Tedesco, Emilie
    Berger, Anne-Emmanuelle
    Vedrines, Philippe
    Duru, Gerard
    Peyrin-Biroulet, Laurent
    Nancey, Stephane
    Flourie, Bernard
    Paul, Stephane
    GUT, 2020, 69 (07) : 1206 - 1212
  • [37] Audit of anti-TNFα antibodies in clinical practice
    Arnott, IDR
    McDonald, D
    Williams, A
    Ghosh, S
    GUT, 2001, 48 : A19 - A20
  • [38] Treatment of Kawasaki disease with anti-TNF antibodies
    Levin, Michael
    Burgner, David
    LANCET, 2014, 383 (9930): : 1700 - 1703
  • [39] Alternative for Anti-TNF Antibodies for Arthritis Treatment
    Paquet, Joseph
    Henrionnet, Christel
    Pinzano, Astrid
    Vincourt, Jean-Baptiste
    Gillet, Pierre
    Netter, Patrick
    Chary-Valckenaere, Isabelle
    Loeuille, Damien
    Pourel, Jacques
    Grossin, Laurent
    MOLECULAR THERAPY, 2011, 19 (10) : 1887 - 1895
  • [40] Successful Switch of Patients with Rheumatoid Arthritis Developing Anti-tumor Necrosis Factor (anti-TNF)-induced Lupus to Another Anti-TNF Agent
    Ye, Carrie
    Sholter, Dalton
    Martin, Liam
    Keeling, Stephanie
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1216 - 1217
12345